An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity
Open Access
- 13 February 2018
- journal article
- review article
- Published by Hindawi Limited in Clinical and Developmental Immunology
- Vol. 2018, 1-22
- https://doi.org/10.1155/2018/6431694
Abstract
Drug hypersensitivity may manifest ranging from milder skin reactions (e.g., maculopapular exanthema and urticaria) to severe systemic reactions, such as anaphylaxis, drug reactions with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS), or Stevens–Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN). Current pharmacogenomic studies have made important strides in the prevention of some drug hypersensitivity through the identification of relevant genetic variants, particularly for genes encoding drug-metabolizing enzymes and human leukocyte antigens (HLAs). The associations identified by these studies are usually drug, phenotype, and ethnic specific. The drug presentation models that explain how small drug antigens might interact with HLA and T cell receptor (TCR) molecules in drug hypersensitivity include the hapten theory, the p-i concept, the altered peptide repertoire model, and the altered TCR repertoire model. The broad spectrum of clinical manifestations of drug hypersensitivity involving different drugs, as well as the various pathomechanisms involved, makes the diagnosis and management of it more challenging. This review highlights recent advances in our understanding of the predisposing factors, immune mechanisms, pathogenesis, diagnostic tools, and therapeutic approaches for drug hypersensitivity.Keywords
Funding Information
- National Science Council (MOST103-2321-B-182-001, MOST101-2628-B-182-001-MY3, MOST104-2314-B-182A-148-MY3, MOST104-2325-B-182A-006, CLRPG2E0051~3, CORPG3F0041~2, OMRPG3E0041, CMRPG1F0111~2)
This publication has 191 references indexed in Scilit:
- Association of Human Leukocyte Antigen Alleles and Nevirapine Hypersensitivity in a Malawian HIV-Infected PopulationClinical Infectious Diseases, 2013
- Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoireProceedings of the National Academy of Sciences, 2012
- Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II AllelesGastroenterology, 2011
- World Allergy Organization anaphylaxis guidelines: SummaryJournal of Allergy and Clinical Immunology, 2011
- Drug hypersensitivity: Pharmacogenetics and clinical syndromesJournal of Allergy and Clinical Immunology, 2011
- Carbamazepine, HLA-B*1502 and Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: US FDA RecommendationsPharmacogenomics, 2008
- A Complex Interaction Between Drug Allergy and Viral InfectionClinical Reviews in Allergy & Immunology, 2007
- Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactionsPharmacogenetics and Genomics, 2006
- Relationship Between Human Leucocyte Antigen Class I and Class II and Chronic Idiopathic Urticaria Associated With Aspirin and/or NSAIDs HypersensitivityMediators of Inflammation, 2006
- Erlotinib in Previously Treated Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005